03 Profile
Vital Signsby Bridgehead
Hansard to 11 November 2026 · 31,429 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Cancer
Amy Armstrong: no photograph is held, so the academic plate is shown instead.
Academic
Amy Armstrong
Principal investigator for the Phase 1/2 HLX-4310 trial
1
0
0
0
0
July 2026Aug 2026Sept 2026Oct 2026Nov 2026to date
1
press citation on 1 topic since 24 Jul 2026 · last quoted 24 Jul 2026
02 Quoted on · 1 of 29 topics
Amy Armstrong: key facts
- Kind of voice
- Academic
- Role
- Principal investigator for the Phase 1/2 HLX-4310 trial
- Quoted on
- Cancer
- Tracked press citations
- 1
- Most recently quoted
- 24 Jul 2026
04 On the record · press
What Amy Armstrong has said
By outlet · linked articles
- cambridgeindependent.co.uk1
Where Amy Armstrong has been quoted
- 01First patient is dosed in Healx HLX-4310 trial backed by Sunshine Project consortiumcambridgeindependent.co.uk · 24 Jul 2026
Verbatim
“I'm excited to see this study begin dosing patients and to evaluate a strategy that is explicitly focused on preventing metastatic recurrence.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
- I'm a Top Oncologist: 5 Women's Health Symptoms I'd Never Ignoremarieclaire.co.uk
- Somerset residents urged to look out for mouth cancer symptomsburnhamandhighbridgeweeklynews.co.uk
- Two-minute mouth checks could help save lives in Somersetchardandilminsternews.co.uk
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 12 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.